We would like to inform you about three HERA calls under EU4Health that are now open for proposals:
💉 Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines 💉
Scope: This call for tenders seeks to accelerate the development of next-generation, rapidly scalable influenza vaccines with innovative production platforms, novel administration routes, broad protection against pandemic influenza A viruses, and intrinsic immunogenicity, through a phased Pre-Commercial Procurement process. This is a competitive procedure with negotiation with a maximum contract duration of 98 months.
⏰ 19/05/2025 15:00 Europe/Brussels
💶 EUR 225Mio (per service contract established = phase 1 – EUR 12.95Mio, Phase II – EUR 35Mio (estimate), and Phase III – EUR 100Mio (estimate) – see ‘tender specifications’ document)
🔗 Next-generation Influenza Vaccine F&Ts Application Webpage
🔬 Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device 🔬
Scope: This call for tenders seeks to accelerate the development of rapid point-of-care diagnostic devices providing antimicrobial susceptibility results within one hour, ideally with pathogen identification, targeting priority bacterial and fungal pathogens, progressing from TRL 3+ towards CE marking and TRL 8 qualification. This is a competitive procedure with negotiation with a maximum contract duration of 48 months.
⏰ 12/05/2025 16:00 Europe/Brussels
💶 EUR 12.86Mio
🔗 PoC AMR/AST Diagnostic Device F&Ts Application Webpage
🦠 Speed up the access to and uptake of an Mpox vaccine 🦠
Scope: This call for tenders aims to generate scientific evidence on the immune response to the MVA-BN vaccine, focusing on the need and optimal timing of booster doses through Phase II and/or III clinical trials, comparing intradermal and subcutaneous administration, to inform public health strategies, EU policies, and stockpiling initiatives. This is an open procedure with a maximum contract duration of 36 months.
⏰ 21/04/2025 16:00 Europe/Brussels
💶 EUR 4.9Mio
🔗 Mpox Vaccine Study F&Ts Application Webpage
Finally, we invite you to update yourself on these, or any subsequent calls, by checking regularly HaDEA’s website and LinkedIn, HERA’s website, and the EU in Emergencies LinkedIn.